SCHEDULE 13D/A 0001731122-25-000961 0001949366 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 07/17/2025 false 0000355019 344437108 FONAR Corp

110 MARCUS DR Melville NY 11747

Dennis C. O'Rourke, Esq. 516-873-2000 Moritt Hock & Hamroff LLP 400 Garden City Plaza Garden City NY 11530 0001949366 N Timothy Raymond Damadian a PF N X1 121553.00 0.00 121553.00 0.00 121553.00 N 1.9 IN Y Luciano Benedetto Bonanni a PF N X1 54253.00 0.00 54253.00 0.00 54253.00 N 0.9 IN Y Ronald George Lehman II a OO N X1 4330.00 0.00 4330.00 0.00 4330.00 N 0.1 IN Y Richard Alan Feigenbaum a OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Y Xavier Patrick Rodrigo a OO N X1 37196.00 0.00 37196.00 0.00 37196.00 N 0.6 IN Y Jevan Damadian a PF N X1 78853.00 0.00 78853.00 0.00 78853.00 N 1.3 IN Y James Joseph Flanagan a PF N X1 8851.00 0.00 8851.00 0.00 8851.00 N 0.1 IN Y Kurt William Reimann a PF N X1 2000.00 0.00 2000.00 0.00 2000.00 N 0.1 IN Y Janice Veroline a OO N X1 7697.00 0.00 7697.00 0.00 7697.00 N 0.1 IN Y James Persoons a OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Common Stock, $0.0001 par value per share FONAR Corp 110 MARCUS DR Melville NY 11747 This Amendment No. 1 ("Amendment No. 1") amends the Schedule 13D jointly filed with the U.S. Securities and Exchange Commission on July 11, 2025 (the "Initial Schedule 13D") on behalf of: Timothy Raymond Damadian ("T. Damadian"), Luciano Benedetto Bonanni ("Bonanni"), Ronald George Lehman II ("Lehman"), Richard Alan Feigenbaum ("Feigenbaum"), Xavier Patrick Rodrigo ("Rodrigo"), Jevan Damadian ("J. Damadian"), James Joseph Flanagan ("Flanagan"), Kurt William Reimann ("Reimann"), Janice Veroline ("Veroline"), and James Persoons ("Persoons"), with respect to the common stock, par value $0.0001 per share (the "Common Stock"), of FONAR Corporation, a Delaware corporation (the "Issuer"). The foregoing persons are hereinafter sometimes referred to, collectively, as "Reporting Persons" and, individually, as a "Reporting Person." Except as specifically set forth in this Amendment No. 1, there are no changes or supplements to the information set forth in the Initial Schedule 13D. Since the filing of the Initial Schedule 13D, none of the Reporting Persons have acquired or disposed of any securities of the Issuer, including shares of Common Stock. Item 4 is hereby supplemented by the following: On July 17, 2025, T. Damadian, on behalf of the Reporting Persons, delivered a letter to the special committee of the Board of Directors of the Issuer providing further information concerning the proposal of the Reporting Persons to the Issuer to acquire the Issuer, including the proposed per share acquisition price for the shares of Common Stock of the Issuer. A copy of such letter is attached as Exhibit 3 to this Schedule 13D. Item 7 is hereby supplemented by the following: Exhibit 3 - Letter to the Special Committee of the Board of Directors of Issuer, dated July 17, 2025. Timothy Raymond Damadian /s/ Timothy Raymond Damadian 07/17/2025 Luciano Benedetto Bonanni /s/ Luciano Benedetto Bonanni 07/17/2025 Ronald George Lehman II /s/ Ronald George Lehman II 07/17/2025 Richard Alan Feigenbaum /s/ Richard Alan Feigenbaum 07/17/2025 Xavier Patrick Rodrigo /s/ Xavier Patrick Rodrigo 07/17/2025 Jevan Damadian /s/ Jevan Damadian 07/17/2025 James Joseph Flanagan /s/ James Joseph Flanagan 07/17/2025 Kurt William Reimann /s/ Kurt William Reimann 07/17/2025 Janice Veroline /s/ Janice Veroline 07/17/2025 James Persoons /s/ James Persoons 07/17/2025